Navigation Links
Wyss Institute Launches "Molecular Origami" Interactive Feature
Date:1/28/2010

Molecular Origami is a process that allows researchers to build nano-sized structures out of DNA (or RNA). To help illustrate the basics of DNA origami, Harvard’s Wyss Institute has created a Flash-based interactive feature that allows users to build virtual nanostructures by sequencing a simple, abstract representation of a DNA molecule and then allowing it to self assemble.

Boston, Mass. (PRWEB) January 28, 2010 -- Molecular Origami is a process that allows researchers to build nano-sized structures out of DNA (or RNA). To help illustrate the basics of DNA origami, Harvard’s Wyss Institute has created a Flash-based interactive feature that allows users to build virtual nanostructures by sequencing a simple, abstract representation of a DNA molecule and then allowing it to self assemble. Users can build structures of their own design – the dynamic nature of the feature allows for an endless number of design possibilities – or they can build and modify pre-set shapes.


Everyone knows the purpose of DNA, and that is to carry the genetic information for all life on earth -- the function it has been performing for billions of years. But over the past three decades researchers have explored the use of DNA for a whole new purpose: as a building material. This new process is called DNA origami because a long strand of DNA is programmed to fold in on itself to create pre-designed shapes, much like a single sheet of paper is folded to create a variety of designs in the traditional Japanese art.

Scientists at the Wyss Institute, led by Core Faculty members, William Shih and Peng Yin, have extended this work toward building complex, three-dimensional structures out of DNA. This work could lead to breakthroughs in manufacturing and medicine. For example, these incredibly tiny forms could be used as cogs in a machine for molecular manufacturing, optical reporters for bioimaging, or carriers for delivery of cancer drugs deep inside the body.

With DNA origami, researchers take a long, single strand of DNA (called a scaffold) and fold it into a structure of their own design. These designs are held together with short "staple" strands, which are also made of DNA. Each staple is coded with two specific sequences: one is the complement to a specific site on the scaffold; the other is the complement to a second location on the same scaffold. When the scaffold and staples are allowed to "self-assemble," the attachment of the staple strands causes the scaffold to bend and fold into the desired structure. In principle, the same approach could be used with RNA or any other informational molecule where complementary sequences can be engineered.

This interactive feature, created by the Wyss Institute for Biologically Inspired Engineering at Harvard, is designed to illustrate the basics of molecular folding in a fun way. So drag and drop the pairs of staples and see how the altering sequences you select can produce virtually any shape you desire, as well as forms that might surprise you.

http://wyss.harvard.edu/viewpage/m-o/interactive-feature-molecular-origami

###

Read the full story at http://www.prweb.com/releases/Wyss_Institute/DNA_origami/prweb3528594.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
4. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
5. Solazyme Selected for National Institute of Standards and Technology Award
6. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
7. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
8. National Institutes of Health Awards $25.5M Contract to SRA
9. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
10. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
11. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Wyss Institute Launches "Molecular Origami" Interactive Feature
(Date:3/23/2017)... 23, 2017  BioPharmX Corporation (NYSE MKT: BPMX), ... dermatology market, today reported financial results for the ... will provide an update on the company,s clinical ... "We are pleased to report that last ... said President Anja Krammer. "We achieved key clinical ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... closer look at four equities in the Biotech industry: ... EYEG), Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus ... March 21 st , 2017, Credit Suisse upgraded its rating ... stocks by downloading their free report at: ...
(Date:3/22/2017)... Mass. (PRWEB) , ... March 22, 2017 , ... ... scale up human tissue regeneration from small lab samples to full-size tissues, bones, ... how to establish a vascular system that delivers blood deep into the developing ...
Breaking Biology Technology:
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader ... its elite iris biometric solution on the latest ... LTE at Mobile World Congress 2017 (February ... Booth in Hall 3, Stand 3E10. ... Qualcomm Haven™ security platform—a combination of hardware, ...
(Date:2/16/2017)... SAN FRANCISCO , Feb. 16, 2017 /PRNewswire/ ... research, today announced that it has received Laboratory ... The CAP Accreditation is presented to laboratories that ... and who demonstrate scientifically rigorous processes. ... of excellence in laboratory practices. We,re honored to ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
Breaking Biology News(10 mins):